{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:29:00Z","timestamp":1771658940508,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1532\/ijh97.06009","type":"journal-article","created":{"date-parts":[[2006,6,21]],"date-time":"2006-06-21T20:31:27Z","timestamp":1150921887000},"page":"443-449","source":"Crossref","is-referenced-by-count":44,"title":["Clinical Features of Polycythemia Vera and Essential Thrombocythemia in Japan: Retrospective Analysis of a Nationwide Survey by the Japanese Elderly Leukemia and Lymphoma Study Group"],"prefix":"10.1007","volume":"83","author":[{"given":"Kazuo","family":"Dan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichirou","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiko","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Pierre R, Imbert M, Thiele J, Vardiman JW, Brunning RD, Flandrin G. Polycythemia vera. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.<i>World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of Hematopoietic and Lymphoid Tissues<\/i>. Lyon, France: IARC Press; 2001: 32-34."},{"key":"E00002","unstructured":"Imbert M, Pierre R, Thiele J, Vardiman JW, Brunning RD, Flandrin G. Essential thrombocythemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds<i>World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of Hematopoietic and Lymphoid Tissues<\/i>. Lyon, France: IARC Press; 2001: 39-41."},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. <i>Blood<\/i>. 1981;<b>58<\/b>:916-919.","DOI":"10.1182\/blood.V58.5.916.bloodjournal585916"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976;<b>295<\/b>:913-916.","DOI":"10.1056\/NEJM197610212951702"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Kippel S, Strunck E, Busse CE, Behringer D, Pahl HL. Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood. 2002;<b>100<\/b>:2441-2448.","DOI":"10.1182\/blood-2002-03-0949"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Teofili L, Martini M, Luongo M, et al. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. J Clin Oncol. 2002;<b>20<\/b>:4249-4254.","DOI":"10.1200\/JCO.2002.11.507"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Harrison CN, Gale RE, Pezelia F, Mire-Sluis A, Machin SJ, Linch DC. Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. Br J Haematol. 1999;<b>107<\/b>:139-147.","DOI":"10.1046\/j.1365-2141.1999.01667.x"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Moliterno A, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med. 1998;<b>338<\/b>:572-580.","DOI":"10.1056\/NEJM199802263380903"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;<b>352<\/b>:1779-1790.","DOI":"10.1056\/NEJMoa051113"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Pearson TC, Messinezy M, Westwood N. A polycythemia vera update: diagnosis, pathobiology, and treatment. Hematology (Am Soc Hematol Educ Program). 2000: 51-68.","DOI":"10.1182\/asheducation-2000.1.51"},{"key":"E00011","unstructured":"Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. <i>Semin Hematol<\/i>. 1997;<b>34<\/b>:29-39."},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Nielsen I, Hasselbalch HC. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan. Am J Hematol. 2003;<b>74<\/b>:26-31.","DOI":"10.1002\/ajh.10375"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Spivak JL, Barosi G, Tognoni G, et al. Chronic myeloproliferative disorders. Hematology (Am Soc Hematol Educ Program). 2003: 200-224.","DOI":"10.1182\/asheducation-2003.1.200"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med. 1995;<b>123<\/b>:656-664.","DOI":"10.7326\/0003-4819-123-9-199511010-00003"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Streiff MB, Smith B, Spivak JL. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood. 2002;<b>99<\/b>:1144-1149.","DOI":"10.1182\/blood.V99.4.1144"},{"key":"E00016","unstructured":"Levine SP. Thrombocytosis. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, eds.Wintrobe's Clinical Hematology. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2004: 1591-1601."},{"key":"E00017","unstructured":"Means RT. Polycythemia vera. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, eds<i>Wintrobe's Clinical Hematology<\/i>. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2004: 2259-2272."},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Elliott MA, Tefferi A. Thrombosis and haemorrhage in poly-cythaemia vera and essential thrombocythaemia. <i>Br J Haematol<\/i>. 2005;<b>128<\/b>:275-290.","DOI":"10.1111\/j.1365-2141.2004.05277.x"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Tefferi A, Solberg LA, Silverstein MN. A clinical update in polycythemia vera and essential thrombocythemia. Am J Med. 2000;<b>109<\/b>:141-149.","DOI":"10.1016\/S0002-9343(00)00449-6"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Tefferi A, Fonseca R, Pereira DL, Hoagland HC. A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc. 2001;<b>76<\/b>:22-28.","DOI":"10.4065\/76.1.22"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Finazzi G, Caruso V, Marchioli R, et al, for the ECLAP Investigators. Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood. 2005;<b>105<\/b>:2664-2670.","DOI":"10.1182\/blood-2004-09-3426"},{"key":"E00022","unstructured":"Wurster-Hill D, Whang-Peng J, McIntyre OR, et al. Cytogenic studies in polycythemia vera. Semin Hematol. 1976;<b>13<\/b>:13-32."},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Berger R, Bernheim A, LeConiat M, et al. Chromosome studies in polycythemia vera patients. Cancer Genet Cytogenet. 1984;<b>12<\/b>: 217-223.","DOI":"10.1016\/0165-4608(84)90033-5"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Passamonti F, Rumi E, Pungolino E, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med. 2004;<b>117<\/b>:755-761.","DOI":"10.1016\/j.amjmed.2004.06.032"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Cervantes F, Alvarrez-Larran A, Talarn C, Gomez M, Monteserrat E. Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. Br J Haematol. 2002;<b>118<\/b>:786-790.","DOI":"10.1046\/j.1365-2141.2002.03688.x"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Barbui T. The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both? Semin Hematol. 2004;<b>41<\/b>(2 suppl 3):15-17.","DOI":"10.1053\/j.seminhematol.2004.02.006"},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"Finazzi G, Harrison C. Essential thrombocythemia. <i>Semin Hematol<\/i>. 2005;<b>42<\/b>:230-238.","DOI":"10.1053\/j.seminhematol.2005.05.022"},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"James C, Ugo V, Le Couredic J-P, et al. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera. Nature. 2005;<b>434<\/b>:1144-1148.","DOI":"10.1038\/nature03546"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.06009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:49:05Z","timestamp":1586972945000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.06009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,6,1]]}},"alternative-id":["WX712350227R2223"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.06009","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}